52154 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 13
13:19 UTC
|
CSCO
Cisco Systems
|
◎ Target | Mike Genovese not yet tracked | Buy | $150.00→ $165.00+10.0% |
|
Aug 13
13:19 UTC
|
CC
Chemours
|
◎ Target | John McNulty ★★★☆☆ #1175 | Outperform | $26.00→ $18.00-30.8% |
|
Aug 13
13:19 UTC
|
CBRS
Cerebras Systems
|
◎ Target | Vijay Rakesh ★★★☆☆ #2191 | Outperform | $310.00→ $300.00-3.2% |
|
Aug 13
13:19 UTC
|
CBRS
Cerebras Systems
|
◎ Target | Joseph Moore ★★☆☆☆ #2332 | Overweight | $273.00→ $279.00+2.2% |
|
Aug 13
13:19 UTC
|
BTGO
BTGO
|
◎ Target | Chris Brendler ★★☆☆☆ #2396 | Buy | $15.00→ $10.00-33.3% |
|
Aug 13
13:19 UTC
|
ASM
Avino Silver & Gold Mines
|
◎ Target | Heiko F. Ihle not yet tracked | Buy | $10.25→ $10.50+2.4% |
|
Aug 13
13:19 UTC
|
ANRO
Alto Neuroscience
|
◎ Target | Laura Chico ★★☆☆☆ #2654 | Neutral | $24.00→ $26.00+8.3% |
|
Aug 13
13:19 UTC
|
AII
American Integrity Insurance Group
|
◎ Target | Paul Newsome ★★★★☆ #648 | Overweight | $23.00→ $26.00+13.0% |
|
Aug 13
13:19 UTC
|
TROX
Tronox
|
↓ Downgrade | firm only | Neutral→ Underweight | $5.00 |
|
Aug 13
13:19 UTC
|
SM
SM Energy
|
↑ Upgrade | Hanwen Chang ★★★☆☆ #1095 | Equal Weight→ Overweight | $32.00→ $47.00+46.9% |
|
Aug 13
13:19 UTC
|
SBSW
Sibanye Gold
|
↑ Upgrade | firm only | Neutral→ Buy | $13.50 |
|
Aug 13
13:19 UTC
|
POR
Portland General Electric
|
↑ Upgrade | firm only | Neutral→ Buy | $48.50 |
|
Aug 13
13:19 UTC
|
OGS
ONE Gas
|
↑ Upgrade | firm only | Neutral→ Buy | $85.50 |
|
Aug 13
13:19 UTC
|
KDP
Keurig Dr Pepper
|
↑ Upgrade | firm only | Hold→ Buy | $40.00 |
|
Aug 13
13:19 UTC
|
INO
Inovio Pharmaceuticals
|
↑ Upgrade | firm only | Hold→ Positive | $3.00 |
|
Aug 13
13:19 UTC
|
ESTA
Establishment Labs
|
↑ Upgrade | Joanne Wuensch ★★★★☆ #488 | Neutral→ Buy | $92.00 |
|
Aug 13
13:19 UTC
|
BRSL
Brightstar Lottery
|
↑ Upgrade | David Katz ★★☆☆☆ #2487 | Hold→ Buy | $16.00 |
|
Aug 13
13:19 UTC
|
BIIB
Biogen
|
↑ Upgrade | firm only | Peer Perform→ Outperform | $300.00 |
|
Aug 13
13:19 UTC
|
ANNX
Annexon
|
↑ Upgrade | Jonathan Wolleben ★☆☆☆☆ #3055 | Underperform→ Market Perform | |
|
Aug 13
13:19 UTC
|
AKAM
Akamai Technologies
|
↑ Upgrade | firm only | Underweight→ Neutral | $158.00 |
|
Aug 13
13:19 UTC
|
ABT
Abbott Laboratories
|
↑ Upgrade | firm only | Peer Perform→ Outperform | $130.00 |
|
Aug 13
12:19 UTC
|
WSM
Williams-Sonoma
|
◎ Target | Cristina Fernandez ★★★☆☆ #1099 | Outperform | $225.00→ $255.00+13.3% |
|
Aug 13
12:19 UTC
|
NBIS
Nebius Group
|
◎ Target | Rob Oliver not yet tracked | Outperform | $250.00→ $340.00+36.0% |
|
Aug 13
12:19 UTC
|
MMSI
Merit Medical Systems
|
◎ Target | Craig Bijou ★★★☆☆ #1608 | Neutral | $92.00→ $97.00+5.4% |
|
Aug 13
12:19 UTC
|
MLTX
MoonLake Immunotherapeutics
|
◎ Target | Raghuram Selvaraju not yet tracked | Buy | $45.00→ $50.00+11.1% |
|
Aug 13
12:19 UTC
|
LQDA
Liquidia
|
◎ Target | Jason Gerberry ★★★☆☆ #2250 | Neutral | $79.00→ $92.00+16.5% |
|
Aug 13
12:19 UTC
|
LFTO
Liftoff Mobile
|
◎ Target | Deepak Mathivanan ★★☆☆☆ #2688 | Overweight | $33.00→ $32.00-3.0% |
|
Aug 13
12:19 UTC
|
JMIA
Jumia Technologies
|
◎ Target | Deepak Mathivanan ★★☆☆☆ #2688 | Overweight | $16.00→ $11.00-31.2% |
|
Aug 13
12:19 UTC
|
HYPD
Hyperion DeFi
|
◎ Target | Gareth Gacetta not yet tracked | Overweight | $6.60→ $7.10+7.6% |
|
Aug 13
12:19 UTC
|
FRVO
Fervo Energy
|
◎ Target | Ben Kallo ★☆☆☆☆ #3219 | Outperform | $50.00→ $35.00-30.0% |
|
Aug 13
12:19 UTC
|
FCCO
First Community
|
◎ Target | firm only | Outperform | $36.00→ $37.50+4.2% |
|
Aug 13
12:19 UTC
|
EAT
Brinker International
|
◎ Target | Jim Salera ★★☆☆☆ #2710 | Overweight | $220.00→ $300.00+36.4% |
|
Aug 13
12:19 UTC
|
EAT
Brinker International
|
◎ Target | Nick Setyan ★★★☆☆ #1662 | Outperform | $175.00→ $275.00+57.1% |
|
Aug 13
12:19 UTC
|
DOC
Healthpeak Properties
|
◎ Target | Amanda Sweitzer ★★★★★ #88 | Outperform | $21.00→ $24.00+14.3% |
|
Aug 13
12:19 UTC
|
DFTX
Definium Therapeutics
|
◎ Target | Christopher Chen not yet tracked | Outperform | $57.00→ $75.00+31.6% |
|
Aug 13
12:19 UTC
|
CSCO
Cisco Systems
|
◎ Target | Meta Marshall ★★★☆☆ #1903 | Overweight | $130.00→ $135.00+3.8% |
|
Aug 13
12:19 UTC
|
CRM
Salesforce
|
◎ Target | firm only | Buy | $200.00→ $222.00+11.0% |
|
Aug 13
12:19 UTC
|
AOSL
Alpha and Omega Semiconductor
|
◎ Target | David Williams ★★★☆☆ #1335 | Buy | $50.00→ $45.00-10.0% |
|
Aug 13
12:19 UTC
|
ANRO
Alto Neuroscience
|
◎ Target | Thomas Shrader ★★☆☆☆ #2348 | Buy | $28.00→ $37.00+32.1% |
|
Aug 13
12:19 UTC
|
ANDG
Andersen Group
|
◎ Target | Tobey Sommer ★★★★☆ #796 | Buy | $42.00→ $55.00+31.0% |
|
Aug 13
12:19 UTC
|
ANDG
Andersen Group
|
◎ Target | Mark Marcon ★★★★☆ #611 | Outperform | $44.00→ $57.00+29.5% |
|
Aug 13
12:19 UTC
|
MNPR
Monopar Therapeutics
|
↓ Downgrade | Kristen Kluska ★☆☆☆☆ #3076 | Overweight→ Neutral | $109.00→ $119.00+9.2% |
|
Aug 13
12:19 UTC
|
BETR
Better Home & Finance
|
↓ Downgrade | Ramsey El-Assal not yet tracked | Overweight→ Neutral | $32.00→ $16.00-50.0% |
|
Aug 13
12:19 UTC
|
WYFI
WhiteFiber
|
↑ Upgrade | Brett Knoblauch ★☆☆☆☆ #3186 | Neutral→ Overweight | $27.00→ $36.00+33.3% |
|
Aug 13
12:19 UTC
|
HYLN
Hyliion
|
↑ Upgrade | Ted Jackson ★★★☆☆ #1860 | Market Perform→ Outperform | $10.00 |
|
Aug 13
12:19 UTC
|
CAVA
CAVA Group
|
↑ Upgrade | firm only | Sell→ Neutral | |
|
Aug 13
12:19 UTC
|
BIIB
Biogen
|
↑ Upgrade | firm only | Outperform | $300.00 |
|
Aug 13
12:19 UTC
|
ABBV
AbbVie
|
↑ Upgrade | firm only | Peer Perform→ Outperform | $300.00 |
|
Aug 13
11:19 UTC
|
SDLF
Standard Life
|
◎ Target | firm only | Overweight | GBX 975→ GBX 1,075+10.3% |
|
Aug 13
11:19 UTC
|
LGEN
Legal & General Group
|
◎ Target | firm only | Underweight | GBX 285→ GBX 270-5.3% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.